Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$3.00+0.07 (+2.39%)
Close on Nov 11, 2026Market cap $126.37MP/E –Yield –
Apyx Medical cash
Cash and short-term investments held at the end of each period.
Apyx Medical's cash was $25.78M at Sep 30, 2026. For fiscal 2025 it was $31.74M, down 0.0% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $115.39M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.74M | -0.0% |
| FY2024 | Dec 31, 2024 | $31.74M | -27.3% |
| FY2023 | Dec 31, 2023 | $43.65M | +328.3% |
| FY2022 | Dec 31, 2022 | $10.19M | -67.0% |
| FY2021 | Dec 31, 2021 | $30.87M | -62.2% |
| FY2020 | Dec 31, 2020 | $81.58M | -29.3% |
| FY2019 | Dec 31, 2019 | $115.39M | +47.4% |
| FY2018 | Dec 31, 2018 | $78.27M | +633.7% |
| FY2017 | Dec 31, 2017 | $10.67M | -30.0% |
| FY2016 | Dec 31, 2016 | $15.24M | +20.5% |
| FY2015 | Dec 31, 2015 | $12.64M | +120.5% |
| FY2014 | Dec 31, 2014 | $5.73M | -27.7% |
| FY2013 | Dec 31, 2013 | $7.92M | +90.4% |
| FY2012 | Dec 31, 2012 | $4.16M | -14.7% |
| FY2011 | Dec 31, 2011 | $4.88M | +27.5% |
| FY2010 | Dec 31, 2010 | $3.83M | +77.6% |
| FY2009 | Dec 31, 2009 | $2.16M | -16.0% |
| FY2008 | Dec 31, 2008 | $2.56M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $25.78M | +2.6% |
| Q2 FY2026 | Jun 30, 2026 | $27.62M | -5.7% |
| Q1 FY2026 | Mar 31, 2026 | $31.14M | +0.4% |
| Q4 FY2025 | Dec 31, 2025 | $31.74M | -0.0% |
| Q3 FY2025 | Sep 30, 2025 | $25.14M | -10.3% |
| Q2 FY2025 | Jun 30, 2025 | $29.30M | -10.3% |
| Q1 FY2025 | Mar 31, 2025 | $31.01M | -16.8% |
| Q4 FY2024 | Dec 31, 2024 | $31.74M | -27.3% |
| Q3 FY2024 | Sep 30, 2024 | $28.01M | +26.6% |
| Q2 FY2024 | Jun 30, 2024 | $32.68M | +76.8% |
| Q1 FY2024 | Mar 31, 2024 | $37.28M | +129.4% |
| Q4 FY2023 | Dec 31, 2023 | $43.65M | +328.3% |
| Q3 FY2023 | Sep 30, 2023 | $22.13M | +49.2% |
| Q2 FY2023 | Jun 30, 2023 | $18.48M | -7.9% |
| Q1 FY2023 | Mar 31, 2023 | $16.26M | -38.0% |
| Q4 FY2022 | Dec 31, 2022 | $10.19M | -67.0% |
| Q3 FY2022 | Sep 30, 2022 | $14.83M | -52.0% |
| Q2 FY2022 | Jun 30, 2022 | $20.06M | -42.1% |
| Q1 FY2022 | Mar 31, 2022 | $26.23M | -33.7% |
| Q4 FY2021 | Dec 31, 2021 | $30.87M | -62.2% |
| Q3 FY2021 | Sep 30, 2021 | $30.90M | -29.0% |
| Q2 FY2021 | Jun 30, 2021 | $34.67M | -24.9% |
| Q1 FY2021 | Mar 31, 2021 | $39.54M | -23.0% |
| Q4 FY2020 | Dec 31, 2020 | $81.58M | -29.3% |
| Q3 FY2020 | Sep 30, 2020 | $43.54M | -30.1% |
| Q2 FY2020 | Jun 30, 2020 | $46.16M | -31.5% |
| Q1 FY2020 | Mar 31, 2020 | $51.38M | -29.9% |
| Q4 FY2019 | Dec 31, 2019 | $115.39M | +47.4% |
| Q3 FY2019 | Sep 30, 2019 | $62.27M | -35.2% |
| Q2 FY2019 | Jun 30, 2019 | $67.36M | +689.2% |
| Q1 FY2019 | Mar 31, 2019 | $73.30M | +683.0% |
| Q4 FY2018 | Dec 31, 2018 | $78.27M | +633.7% |
| Q3 FY2018 | Sep 30, 2018 | $96.14M | +843.5% |
| Q2 FY2018 | Jun 30, 2018 | $8.54M | -22.9% |
| Q1 FY2018 | Mar 31, 2018 | $9.36M | -23.8% |
| Q4 FY2017 | Dec 31, 2017 | $10.67M | -30.0% |
| Q3 FY2017 | Sep 30, 2017 | $10.19M | – |
| Q2 FY2017 | Jun 30, 2017 | $11.07M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.29M | – |
| Q4 FY2016 | Dec 31, 2016 | $15.24M | – |
See a number that looks wrong?